IGF1R and head and neck squamous cell carcinoma: In addition, the RTKs FGFR1 and IGF1R were identified with activating mutations in 10 and 4 % of HPV- HNSCC, respectively, while no mutations of these kinases were identified in HPV+ HNSCC tumors (Fig. 1a and c).